Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.44
-0.06-3.76%
Pre-Market: 6:40 PM EDT
Comments
Loading...
MediciNova Analyst Ratings and Price Targets | NASDAQ:MNOV | Benzinga
MediciNova Inc has a consensus price target of $9 based on the ratings of 1 analysts. The high is $9 issued by D. Boral Capital on March 14, 2025. The low is $9 issued by D. Boral Capital on March 14, 2025. The 3 most-recent analyst ratings were released by D. Boral Capital on March 14, 2025, February 21, 2025, and December 6, 2024, respectively. With an average price target of $9 between D. Boral Capital, there's an implied 523.44% upside for MediciNova Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
D. Boral Capital
1calculated from analyst ratings
Analyst Ratings for MediciNova
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/14/2025 | Buy Now | 523.44% | D. Boral Capital | Jason Kolbert48% | $9 → $9 | Maintains | Buy | Get Alert |
| 02/21/2025 | Buy Now | 523.44% | D. Boral Capital | Jason Kolbert48% | $9 → $9 | Maintains | Buy | Get Alert |
| 12/06/2024 | Buy Now | 523.44% | D. Boral Capital | Jason Kolbert48% | $9 → $9 | Maintains | Buy | Get Alert |
| 12/02/2024 | Buy Now | 523.44% | D. Boral Capital | Jason Kolbert48% | → $9 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for MediciNova (MNOV) stock?
The latest price target for MediciNova (NASDAQ:MNOV) was reported by D. Boral Capital on March 14, 2025. The analyst firm set a price target for $9.00 expecting MNOV to rise to within 12 months (a possible 523.44% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for MediciNova (MNOV)?
The latest analyst rating for MediciNova (NASDAQ:MNOV) was provided by D. Boral Capital, and MediciNova maintained their buy rating.
When was the last upgrade for MediciNova (MNOV)?
There is no last upgrade for MediciNova
When was the last downgrade for MediciNova (MNOV)?
There is no last downgrade for MediciNova.
When is the next analyst rating going to be posted or updated for MediciNova (MNOV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MediciNova, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MediciNova was filed on March 14, 2025 so you should expect the next rating to be made available sometime around March 14, 2026.
Is the Analyst Rating MediciNova (MNOV) correct?
While ratings are subjective and will change, the latest MediciNova (MNOV) rating was a maintained with a price target of $9.00 to $9.00. The current price MediciNova (MNOV) is trading at is $1.44, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.